SCHEMBL30689348

SCHEMBL30689348

C=C(Cc1nc(-c2ccc(Oc3ccccn3)cc2)no1)C(=O)OC(C)(C)C

nearest known ligand 0.41

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ IP6K1 Q92551 1/20 0.41
▸ IP6K3 Q96PC2 1/20 0.41
▸ IP6K2 Q9UHH9 1/20 0.41
▸ TP53 P04637 3/20 0.40
▸ GSTP1 P09211 4/20 0.40
▸ MITF O75030 1/20 0.39
▸ NCOA3 Q9Y6Q9 1/20 0.39
▸ LMNA P02545 2/20 0.39
▸ ACACB O00763 5/20 0.39
▸ ATM Q13315 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.38
▸ TSHR P16473 1/20 0.38
▸ PPARD Q03181 2/20 0.38
▸ PPARA Q07869 2/20 0.38
▸ DHODH Q02127 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30689347 0.86 IP6K1 (0.48) IP6K1IP6K3IP6K2TP53GSTP1
SCHEMBL30689312 0.85 FPR2 (0.43) GSTP1TSHR
SCHEMBL30689408 0.83 TP53 (0.39) TP53LMNAACACBATMALDH1A1
SCHEMBL25802078 0.83 FFAR1 (0.50) GSTP1TSHRPPARDPPARA
SCHEMBL30689440 0.81 GSTP1 (0.40) TP53GSTP1LMNAALDH1A1TSHR
SCHEMBL23588077 0.81 ACACB (0.52) TP53MITFNCOA3LMNAACACB
SCHEMBL25802137 0.81 MAPT (0.50) LMNAALDH1A1TSHR
SCHEMBL30689327 0.80 GSTP1 (0.42) TP53GSTP1MITFNCOA3LMNA
SCHEMBL25802130 0.80 TP53 (0.42) TP53MITFNCOA3LMNAATM
SCHEMBL25802125 0.80 MEN1 (0.46) TP53GSTP1LMNAATMALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4543875-A1 OXADIAZOLE DERIVATIVES, PREPARATION PROCESS THEREOF AND THEIR USE IN TREATING INFLAMMATORY DISEASES Sitryx Therapeutics Limited (GB) 2025-04-30 — — EP disclosed
WO-2023247958-A1 OXADIAZOLE DERIVATIVES, PREPARATION PROCESS THEREOF AND THEIR USE IN TREATING INFLAMMATORY DISEASES SITRYX THERAPEUTICS LIMITED (GB) 2023-12-28 — — WO disclosed
Send feedback